Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium

Sandy S. Jun, Zhong Chen, Margaret C. Pace, Philip W. Shaul

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Prostacyclin (PGI2) is a key mediator of pulmonary vasodilation in the perinatal period and its synthesis in the pulmonary vasculature increases markedly during late gestation due to enhanced expression of the rate- limiting enzyme cyclooxygenase-1 (COX-1). The hormone estrogen may play a role in COX-1 upregulation since fetal estrogen levels rise dramatically during late gestation and estrogen enhances PGI2 synthesis in nonpulmonary vascular cells. We therefore studied the direct effects of estrogen on COX-1 expression in ovine fetal pulmonary artery endothelial cells (PAEC). Exposure to estradiol-17β (E2β, 10-10 to 10-6 M) caused a dose-related increase in COX-1 mRNA expression that was evident after 48 h and maximal at 10-8 M (fourfold increase). COX-1 mRNA stability was unchanged, suggesting that the upregulation is mediated at the level of transcription. E2β treatment (10-8 M for 48 h) also caused a threefold increase in COX-1 protein expression and a threefold increase in PGI2 synthesis stimulated by bradykinin, the calcium ionophore A23187, or arachidonic acid. The estrogen receptor (ER) antagonist ICI 182,780 fully reversed the effects of the hormone on COX-1 protein expression and on arachidonic acid-stimulated PGI2 synthesis, and ER expression was evident in the PAEC by immunoblot analysis. These findings indicate that physiologic levels of estrogen cause upregulation of COX-1 expression and PGI2 synthesis in fetal PAEC via activation of PAEC ER. This process may play a critical role in optimizing the capacity for PGI2-mediated pulmonary vasodilation at birth, and it may also be involved in estrogen responsiveness in other vascular beds.

Original languageEnglish (US)
Pages (from-to)176-183
Number of pages8
JournalJournal of Clinical Investigation
Volume102
Issue number1
StatePublished - Jul 1 1998

Fingerprint

Cyclooxygenase 1
Pulmonary Artery
Endothelium
Sheep
Estrogens
Epoprostenol
Up-Regulation
Gene Expression
Endothelial Cells
Arachidonic Acid
Vasodilation
Estrogen Receptors
Lung
Blood Vessels
Epoprostenol Receptors
Hormones
Pregnancy
Calcium Ionophores
RNA Stability
Calcimycin

Keywords

  • Estrogen receptor
  • Immunoblotting
  • Polymerase chain reaction
  • Prostacyclin
  • Pulmonary circulation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. / Jun, Sandy S.; Chen, Zhong; Pace, Margaret C.; Shaul, Philip W.

In: Journal of Clinical Investigation, Vol. 102, No. 1, 01.07.1998, p. 176-183.

Research output: Contribution to journalArticle

@article{8d90bf11c8d0408b86980fe39047d911,
title = "Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium",
abstract = "Prostacyclin (PGI2) is a key mediator of pulmonary vasodilation in the perinatal period and its synthesis in the pulmonary vasculature increases markedly during late gestation due to enhanced expression of the rate- limiting enzyme cyclooxygenase-1 (COX-1). The hormone estrogen may play a role in COX-1 upregulation since fetal estrogen levels rise dramatically during late gestation and estrogen enhances PGI2 synthesis in nonpulmonary vascular cells. We therefore studied the direct effects of estrogen on COX-1 expression in ovine fetal pulmonary artery endothelial cells (PAEC). Exposure to estradiol-17β (E2β, 10-10 to 10-6 M) caused a dose-related increase in COX-1 mRNA expression that was evident after 48 h and maximal at 10-8 M (fourfold increase). COX-1 mRNA stability was unchanged, suggesting that the upregulation is mediated at the level of transcription. E2β treatment (10-8 M for 48 h) also caused a threefold increase in COX-1 protein expression and a threefold increase in PGI2 synthesis stimulated by bradykinin, the calcium ionophore A23187, or arachidonic acid. The estrogen receptor (ER) antagonist ICI 182,780 fully reversed the effects of the hormone on COX-1 protein expression and on arachidonic acid-stimulated PGI2 synthesis, and ER expression was evident in the PAEC by immunoblot analysis. These findings indicate that physiologic levels of estrogen cause upregulation of COX-1 expression and PGI2 synthesis in fetal PAEC via activation of PAEC ER. This process may play a critical role in optimizing the capacity for PGI2-mediated pulmonary vasodilation at birth, and it may also be involved in estrogen responsiveness in other vascular beds.",
keywords = "Estrogen receptor, Immunoblotting, Polymerase chain reaction, Prostacyclin, Pulmonary circulation",
author = "Jun, {Sandy S.} and Zhong Chen and Pace, {Margaret C.} and Shaul, {Philip W.}",
year = "1998",
month = "7",
day = "1",
language = "English (US)",
volume = "102",
pages = "176--183",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium

AU - Jun, Sandy S.

AU - Chen, Zhong

AU - Pace, Margaret C.

AU - Shaul, Philip W.

PY - 1998/7/1

Y1 - 1998/7/1

N2 - Prostacyclin (PGI2) is a key mediator of pulmonary vasodilation in the perinatal period and its synthesis in the pulmonary vasculature increases markedly during late gestation due to enhanced expression of the rate- limiting enzyme cyclooxygenase-1 (COX-1). The hormone estrogen may play a role in COX-1 upregulation since fetal estrogen levels rise dramatically during late gestation and estrogen enhances PGI2 synthesis in nonpulmonary vascular cells. We therefore studied the direct effects of estrogen on COX-1 expression in ovine fetal pulmonary artery endothelial cells (PAEC). Exposure to estradiol-17β (E2β, 10-10 to 10-6 M) caused a dose-related increase in COX-1 mRNA expression that was evident after 48 h and maximal at 10-8 M (fourfold increase). COX-1 mRNA stability was unchanged, suggesting that the upregulation is mediated at the level of transcription. E2β treatment (10-8 M for 48 h) also caused a threefold increase in COX-1 protein expression and a threefold increase in PGI2 synthesis stimulated by bradykinin, the calcium ionophore A23187, or arachidonic acid. The estrogen receptor (ER) antagonist ICI 182,780 fully reversed the effects of the hormone on COX-1 protein expression and on arachidonic acid-stimulated PGI2 synthesis, and ER expression was evident in the PAEC by immunoblot analysis. These findings indicate that physiologic levels of estrogen cause upregulation of COX-1 expression and PGI2 synthesis in fetal PAEC via activation of PAEC ER. This process may play a critical role in optimizing the capacity for PGI2-mediated pulmonary vasodilation at birth, and it may also be involved in estrogen responsiveness in other vascular beds.

AB - Prostacyclin (PGI2) is a key mediator of pulmonary vasodilation in the perinatal period and its synthesis in the pulmonary vasculature increases markedly during late gestation due to enhanced expression of the rate- limiting enzyme cyclooxygenase-1 (COX-1). The hormone estrogen may play a role in COX-1 upregulation since fetal estrogen levels rise dramatically during late gestation and estrogen enhances PGI2 synthesis in nonpulmonary vascular cells. We therefore studied the direct effects of estrogen on COX-1 expression in ovine fetal pulmonary artery endothelial cells (PAEC). Exposure to estradiol-17β (E2β, 10-10 to 10-6 M) caused a dose-related increase in COX-1 mRNA expression that was evident after 48 h and maximal at 10-8 M (fourfold increase). COX-1 mRNA stability was unchanged, suggesting that the upregulation is mediated at the level of transcription. E2β treatment (10-8 M for 48 h) also caused a threefold increase in COX-1 protein expression and a threefold increase in PGI2 synthesis stimulated by bradykinin, the calcium ionophore A23187, or arachidonic acid. The estrogen receptor (ER) antagonist ICI 182,780 fully reversed the effects of the hormone on COX-1 protein expression and on arachidonic acid-stimulated PGI2 synthesis, and ER expression was evident in the PAEC by immunoblot analysis. These findings indicate that physiologic levels of estrogen cause upregulation of COX-1 expression and PGI2 synthesis in fetal PAEC via activation of PAEC ER. This process may play a critical role in optimizing the capacity for PGI2-mediated pulmonary vasodilation at birth, and it may also be involved in estrogen responsiveness in other vascular beds.

KW - Estrogen receptor

KW - Immunoblotting

KW - Polymerase chain reaction

KW - Prostacyclin

KW - Pulmonary circulation

UR - http://www.scopus.com/inward/record.url?scp=0032127953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032127953&partnerID=8YFLogxK

M3 - Article

VL - 102

SP - 176

EP - 183

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -